RecruitingNot ApplicableNCT06518824

Theta Deep Brain Stimulation for Cognitive Enhancement in Parkinson's Disease


Sponsor

University of British Columbia

Enrollment

27 participants

Start Date

Jan 23, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Cognitive impairment is common in Parkinson's disease. A recent study demonstrated 40% of people with PD suffer from mild cognitive impairment and \> 80% of patients develop dementia after a disease duration of 20 years. Cognitive impairment significantly impairs quality of life and has limited treatment options. While the pathophysiology of cognitive symptoms in PD is multifactorial, one contributing factor is dysfunction in subthalamic-cortical loops. The subthalamic nucleus (STN) receives input from distributed regions of the cortex, forming partially segregated parallel networks with sensorimotor regions, associative (cognitive) cortical regions, and limbic cortical regions. These subthalamic-cortical networks are thought to play a domain general role in inhibitory control, which is a fundamental mechanism underlying flexible behavior across motor, cognitive, and affective domains. Information processing in these subthalamic-cortical networks is expressed through oscillatory activity within distinct frequency bands. For example, communication between the STN and prefrontal regions involved in executive function is thought to occur through coherence in the theta (4-8 Hz) frequency band. As a result of these observations, stimulation of the STN at a theta frequency has been investigated as a method of modulating cognitive processes. Theta stimulation of the STN has been shown to enhance coherence in subthalamic-cortical networks, facilitating information processing and modulating behavior. For example, a recent study demonstrated that theta stimulation of the STN improved working memory performance in PD subjects, while no effect was seen for other frequency bands. The authors performed a post-hoc analysis and found that the effect may be mediated by connectivity between the stimulated STN region and the right dorsolateral prefrontal cortex (DLPFC). While these studies have demonstrated proof of principle, they are limited by small sample sizes and post-hoc analyses assessing the relationship between stimulation location and outcomes. Further research is needed to directly test the hypothesis that theta stimulation of the STN can improve executive control in PD patients by modulating associative STN circuitry.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether using a specific frequency of electrical stimulation (theta-burst stimulation) through an already-implanted deep brain stimulation (DBS) device can improve memory and thinking in people with Parkinson's disease. DBS devices are surgically placed to help control motor symptoms, and this study explores whether the same device, used differently, could also boost cognitive function. **You may be eligible if...** - You already have a subthalamic nucleus (STN) DBS device implanted for Parkinson's disease - You have both pre-surgery and post-surgery brain imaging available - It has been at least 3 months since your DBS surgery **You may NOT be eligible if...** - You are unable to complete cognitive tests due to a language barrier or dementia - You have had significant complications from your DBS device Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDBS On

The DBS device will be turned on while the patient undergoes the working memory task.

DEVICEDBS Off

The DBS device will be turned off while the patient undergoes the working memory task.


Locations(1)

Leslie and Gordan Diamond Health Care Centre

Vancouver, British Columbia, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06518824


Related Trials